Completed OBSERVATIONAL NCT01044810

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

Comparison of Virological and Immunological Results of Efavirenz-based Regimen in HIV-infected Patients With or Without Allergic Reactions to Nevirapine

Sponsor: Bamrasnaradura Infectious Diseases Institute

Conditions CD4 Cell Counts Treatment Failure, HIV or AIDS

Interventions Efavirenz-based regimens

Updated 6 times since 2017 Last updated: Mar 14, 2011 Started: Jan 31, 2010 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates CD4 Cell Counts and Treatment Failure, HIV or AIDS and is currently completed. Bamrasnaradura Infectious Diseases Institute leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bamrasnaradura Infectious Diseases Institute
Clinical Research Collaborative Network
Thai Red Cross AIDS Research Centre

Data source: Bamrasnaradura Infectious Diseases Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nonthaburi, Thailand